Drug Type Gene therapy |
Synonyms KB 704, KB-704 |
Target |
Action stimulants |
Mechanism IL-2 stimulants(Interleukin-2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | United States | 02 Nov 2023 | |
Skin Neoplasms | Preclinical | United States | 02 Nov 2023 |